TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 23 filers reported holding TALIS BIOMEDICAL CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $43,902 | +54777.5% | 91,463 | -44.1% | 0.00% | – |
| Q1 2023 | $80 | +63.3% | 163,663 | +47.4% | 0.00% | – |
| Q4 2022 | $49 | -99.9% | 111,036 | -14.2% | 0.00% | – |
| Q3 2022 | $88,000 | -46.3% | 129,372 | -35.9% | 0.00% | – |
| Q2 2022 | $164,000 | +4.5% | 201,913 | +1320.0% | 0.00% | – |
| Q2 2021 | $157,000 | – | 14,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $1,095,534 | 0.06% |
| Baker Brothers Advisors | 7,624,835 | $3,736,169 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 223,934 | $109,728 | 0.01% |
| ArrowMark Colorado Holdings LLC | 478,862 | $234,642 | 0.00% |
| WELLS FARGO & COMPANY/MN | 167 | $82 | 0.00% |
| NORTHERN TRUST CORP | 27,860 | $13,652 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 144,416 | $70,763 | 0.00% |
| STATE STREET CORP | 49,536 | $24,273 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 163,663 | $80 | 0.00% |